Company Overview and News
Globus Medical, Inc. (GMED - Free Report) was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $28.86–$31.87 in the past one-month time frame, witnessed a sharp increase yesterday. (2-0)
Welcome to Globus Medical's Third Quarter 2017 Earnings Call. At this time, all lines will be on mute and a Q&A session will be held after the prepared remarks. (52-0)
Paradigm Select Fund (PFSLX - Free Report) seeks appreciation of capital for the long run. PFSLX invests mainly in common stocks of those companies, whose market-cap falls within the range of $500 million and $10 billion. PFSLX focuses on those companies which are expected to have strong capital growth potential. (1-0)
AUDUBON, Pa., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the first spine surgeries using ExcelsiusGPS™, a revolutionary robotic guidance and navigation system. Surgeries using ExcelsiusGPS™ were performed last week at The Johns Hopkins Hospital in Baltimore, Maryland and St. Mark’s Hospital in Salt Lake City, Utah.
LONDON, Oct. 4, 2017 /PRNewswire/ -- The European orthobiologics market is estimated to grow at a CAGR of 6.3% from 2014 to 2019. It is the second-largest market in the global orthobiologics market, followed by North America. Download the full report: https://www.reportbuyer.com/product/4167856 Increasing cases of road accidents, as well as rising prevalence of osteoarthritis are propelling the growth of orthobiologics market in this region. (6-0)
LONDON, Oct. 4, 2017 /PRNewswire/ -- The global orthobiologics market is estimated to grow at a CAGR of 6.7% from 2014 to 2019. The end-user segment of this market is classified into hospitals, orthopedic clinics, and other end-users. Rise in cases of road accidents, as well as increasing awareness among patients with regards to the benefits associated with orthobiologics products are propelling the growth of orthobiologics market. (6-0)
NEW YORK, Oct. 3, 2017 /PRNewswire/ -- The global orthobiologics market is projected to reach USD 6.06 billion by 2022 from USD 4.66 billion in 2017, at a CAGR of 5.4%. Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high incidence of musculoskeletal disorders; and growing patient preference for minimally invasive procedures are driving the orthobiologics market. (0-1)
NEW YORK, Oct. 3, 2017 /PRNewswire/ -- Did you know?- Globus Medical's single-minded focus on advancing spinal surgery has made it the fastest growing company in the history of orthopedics. (15-1)
Zimmer (ZBH) is a US medical devices company focusing on orthopedic implants. Before delving into the company specificities, we are going to have a look to the orthopedic market. (18-0)
Global Orthopaedic Biomaterial Market driven by rising clinical education among the patients, increasing medical applications of biomaterial by orthopaedicians, rising demand from the aged population, and technological innovation has further led to growing focus towards healthcare, hence, building the need for joint replacement surgeries using orthopaedic biomaterial, specifically among the adult population according to ReportsnReports. (37-2)
According to a new market research report "Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC, Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft Tissue), End User (Hospitals, ASCs, Academia) - Global Forecast to 2022", published by MarketsandMarkets™, the market is projected to reach USD 6.06 Billion by 2022 from USD 4. (6-0)
AUDUBON, Pa., Sept. 14, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced it completed its first orthopedic trauma surgical case. Globus Medical’s new ANTHEM™ Distal Radius Fracture System was used by Dr. Asif Ilyas, Hand Surgeon and Trauma Surgeon with The Rothman Institute at Thomas Jefferson University in Philadelphia PA, to successfully treat a distal radius fracture. (1-0)
NEW YORK, Sept. 13, 2017 /PRNewswire/ -- This report on the soft tissue allografts market analyzes the current and future scenario of the global market. Large number of ACL injury patient and diabetes sufferers is increasing the usage of soft tissue allografts. Increasing prevalence of degenerative joint diseases and high definition designed technology are the major drivers of the global soft tissue allografts market.
Based in Audubon, PA, leading musculoskeletal implant company Globus Medical, Inc. (GMED - Free Report) announced the receipt of 510k approval for its Excelsius GPS robotic guidance and navigation system from the FDA.
2017-10-28 - Wilton
2017-10-25 - Wilton
2017-10-10 - Wilton
2017-10-09 - Wilton
2017-08-25 - Wilton